InsidersTradesSigma
Browse the detailed record of transactions filed by Sprague John M, Chief Financial Officer. Officer active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 5 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. History available since 8 April 2022. The latest transaction was disclosed on 8 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
John M. Sprague is the Chief Financial Officer of T2 Biosystems, Inc. He is responsible for the company's financial management, including financial planning and performance analysis. T2 Biosystems is an innovative company specializing in developing diagnostic solutions for the healthcare sector.